Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05926687 · ClinicalTrials.gov registry record · Phase 2
Optimizing Outcomes for Young Autistic Children
A Phase 2 study of Autism Spectrum Disorder and Autism, sponsored by Northwestern University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT05926687 is a Phase 2 study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 184 participants, above the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05926687, a Phase 2 study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of the proposed study is to: (a) determine how best to sequence two parent-mediated interventions: a social communication intervention (Project ImPACT, Improving Parents as Communication Teachers) and a disruptive behavior intervention (Parent Training for Disruptive Behavior) and (b) examine moderators and mediators of intervention outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Social Communication
- BEHAVIORAL Disruptive Behavior
- BEHAVIORAL Social Communication + Reduce Frequency
- BEHAVIORAL Social Communication + Add Tools
- BEHAVIORAL Disruptive Behavior + Reduce Frequency
Study Locations (1)
Illinois
- Northwestern University - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2027-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05926687
The ClinicalTrials.gov registry entry for NCT05926687 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (36% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 5 interventions - of which Social Communication is the first listed.
NCT05926687 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05926687 about?
NCT05926687 is a clinical study titled "Optimizing Outcomes for Young Autistic Children". The overarching goal of the proposed study is to: (a) determine how best to sequence two parent-mediated interventions: a social communication intervention (Project ImPACT, Improving Parents as Communication Teachers) and a disruptive behavior intervention (Parent Training for Disruptive Behavior) a...
What is the current status of trial NCT05926687?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 184 participants. The study started on 2023-07-11. Estimated completion is 2027-02-28.
What conditions does trial NCT05926687 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.
What interventions are being tested in trial NCT05926687?
The interventions under investigation include: Social Communication (BEHAVIORAL), Disruptive Behavior (BEHAVIORAL), Social Communication + Reduce Frequency (BEHAVIORAL), Social Communication + Add Tools (BEHAVIORAL), Disruptive Behavior + Reduce Frequency (BEHAVIORAL).
Who is sponsoring clinical trial NCT05926687?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05926687 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
RECRUITING · Phase 2
-
Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
RECRUITING · Phase 2
-
Trial of Zolpidem for Sleep in Children With Autism
RECRUITING · Phase 2
-
Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD
RECRUITING · Phase 2
-
A Study of Esomeprazole in Children With Autism
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.